Mr. Pape Gaye

Pape Gaye, MBA has been selected by the Triangle Global Health Consortium as our 2019 Triangle Global Health Champion in recognition of his life-long commitment to advancing global health. 

Pape Gaye is a native of Senegal and a lifelong advocate for health workers, strong health systems, and access to health care for all. Under his leadership as president and CEO of IntraHealth International, the organization has made human resources for health a crucial part of the worldwide conversation on global health. Gaye draws on three decades of leadership in international health and development as he oversees work in over 40 countries to strengthen their health workforces and health systems.

​

During his watch, IntraHealth has led two of the US government’s flagship human resources for health projects (the Capacity Project and CapacityPlus) and established official relations with the World Health Organization (WHO). Gaye has long advocated for a greater focus on the health workforce. In May 2016 at the World Health Assembly, the WHO and member states responded to such advocacy efforts with the first-ever global health workforce strategy, Workforce 2030.

Grifols

Grifols is a global healthcare company founded in Barcelona in 1940, committed to improving the health and well-being of people around the world. Its four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.

As pioneers in the field of the plasma science, Grifols is one of the largest plasma companies, with a growing network of donation centers worldwide. It develops this plasma into essential medicines used to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation through transfusion. And the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care. 

​

In December 2018, Grifols began purifying plasma from healthy Ebola survivors from Liberia to produce anti-Ebola immunoglobulin, a potential treatment for patients affected by the Ebola virus in Africa, as part of a longer-term Grifols clinical research program. Grifols's work includes a first-of-its-kind modular plasma donation center that was deployed to Monrovia, Liberia. Grifols also constructed a dedicated processing facility at its Clayton manufacturing complex to produce anti-Ebola Immunoglobulin. The project is the result of collaborative efforts among Grifols, several non-profit organizations and Liberian scientists at the National Public Health Institute of Liberia. As part of the non-profit project, more than 40 Grifols employees and Probitas Foundation (a Grifols philanthropic organization) professionals traveled to Liberia for extended periods and volunteered in the plasma-collection process and community efforts.

Dr. Felicia Browne

Felicia Browne, ScD, MPH, is a social epidemiologist at RTI International in the Substance Use, Gender and Applied Research Program. She has more than a decade of experience adapting and implementing HIV behavioral interventions locally and globally to empower adolescent girls and young women at risk for HIV. She is a Multiple Principal Investigator of a NIDA-funded R01 study testing an mHealth delivery of an HIV prevention intervention in North Carolina health departments for young African American women. She was an integral part of the mHealth development team—ensuring innovative intervention components were included. She is also the Co-Project Director of a NIDA-funded R01 project in South Africa for female adolescents who are out of school, and a Co-Investigator on two NIH-funded R01 projects in South Africa—including one for women living with HIV.

​

Felicia serves on UNC’s community advisory board for HIV research, is a mentor for WomenNC’s leadership program for college students interested in eliminating gender inequities, and volunteers for a Durham-based organization dedicated to addressing health disparities. Felicia received her Doctor of Science in Social Epidemiology from Harvard, her MPH in Health Behavior and Health Education from UNC-Chapel Hill, and her BS in Psychology from Davidson College.

Ms. Chytanya Kompala

Chytanya Kompala serves at the Nutrition Research Program Officer for the Eleanor Crook Foundation based in Raleigh, North Carolina. As a global health nutritionist, Chytanya works to support implementation research on cost-effective solutions to malnutrition in East Africa. Her research focuses include stunting prevention, maternal and child nutrition, micronutrient deficiencies, and the science of scaling. Previously, Kompala worked as a nutrition researcher at PATH and Sight & Life, with experience living and working in East and West Africa. She holds a Master of Science in Public Health degree in Human Nutrition from Johns Hopkins Bloomberg School of Public Health. 

Dr. Jenna Mueller

Dr. Jenna Mueller is a biomedical engineer who works with the Center for Global Women’s Health Technologies at Duke University to develop low-cost devices and therapies to improve the management of cervical cancer in low and middle-income countries (LMICs). She worked with a multidisciplinary team to develop the Pocket colposcope, a low-cost, portable device to screen women for cervical pre-cancer at the primary care setting, and conducted studies to demonstrate its impact in 1000 women in 8 countries.

​

Jenna began her career at Rice University where she developed a passion for global health through working with a team to develop a “Diagnostic Lab in a Backpack” for patients in remote locations. She spent eight weeks in Lesotho evaluating the backpack’s efficacy and visiting remote clinics to gather feedback about its design. Her experience in Lesotho propelled her to continue her education at Duke University where she completed an M.S. and Ph.D. in biomedical engineering with a doctoral certificate in global health.